<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" class="marks" width="574" height="447" viewBox="0 0 574 447"><rect width="574" height="447" fill="white"/><g fill="none" stroke-miterlimit="10" transform="translate(64,87)"><g class="mark-group role-frame root" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h500v300h-500Z" stroke="lightgray" stroke-width="0.5"/><g><g class="mark-group role-axis" aria-hidden="true"><g transform="translate(0.5,0.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-grid" pointer-events="none"><line transform="translate(0,300)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,270)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,240)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,210)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,180)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,150)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,120)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,90)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,60)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,30)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,0)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="X-axis for a discrete scale with 13 values: 0, 1, 2, 3, 4, ending with 12"><g transform="translate(0.5,300.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(19,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(57,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(96,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(134,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(173,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(211,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(250,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(288,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(326,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(365,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(403,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(442,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(480,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="end" transform="translate(18.73076923076924,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">0</text><text text-anchor="end" transform="translate(57.1923076923077,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">1</text><text text-anchor="end" transform="translate(95.65384615384616,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">2</text><text text-anchor="end" transform="translate(134.11538461538464,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">3</text><text text-anchor="end" transform="translate(172.5769230769231,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">4</text><text text-anchor="end" transform="translate(211.03846153846155,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">5</text><text text-anchor="end" transform="translate(249.5,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">6</text><text text-anchor="end" transform="translate(287.9615384615385,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">7</text><text text-anchor="end" transform="translate(326.42307692307696,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">8</text><text text-anchor="end" transform="translate(364.8846153846154,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">9</text><text text-anchor="end" transform="translate(403.34615384615387,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">10</text><text text-anchor="end" transform="translate(441.8076923076923,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">11</text><text text-anchor="end" transform="translate(480.2692307692308,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">12</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,0)" x2="500" y2="0" stroke="black" stroke-width="0.5" opacity="1"/></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="Y-axis titled 'Number of Participants' for a linear scale with values from 0 to 200"><g transform="translate(0.5,0.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(0,300)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,270)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,240)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,210)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,180)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,150)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,120)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,90)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,60)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,30)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,0)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="end" transform="translate(-7,303)" font-family="Arial" font-size="11px" fill="black" opacity="1">0</text><text text-anchor="end" transform="translate(-7,273)" font-family="Arial" font-size="11px" fill="black" opacity="1">20</text><text text-anchor="end" transform="translate(-7,243)" font-family="Arial" font-size="11px" fill="black" opacity="1">40</text><text text-anchor="end" transform="translate(-7,213)" font-family="Arial" font-size="11px" fill="black" opacity="1">60</text><text text-anchor="end" transform="translate(-7,183)" font-family="Arial" font-size="11px" fill="black" opacity="1">80</text><text text-anchor="end" transform="translate(-7,153)" font-family="Arial" font-size="11px" fill="black" opacity="1">100</text><text text-anchor="end" transform="translate(-7,123)" font-family="Arial" font-size="11px" fill="black" opacity="1">120</text><text text-anchor="end" transform="translate(-7,93.00000000000001)" font-family="Arial" font-size="11px" fill="black" opacity="1">140</text><text text-anchor="end" transform="translate(-7,62.999999999999986)" font-family="Arial" font-size="11px" fill="black" opacity="1">160</text><text text-anchor="end" transform="translate(-7,32.99999999999999)" font-family="Arial" font-size="11px" fill="black" opacity="1">180</text><text text-anchor="end" transform="translate(-7,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">200</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,300)" x2="0" y2="-300" stroke="black" stroke-width="0.5" opacity="1"/></g><g class="mark-text role-axis-title" pointer-events="none"><text text-anchor="middle" transform="translate(-40.35302734375,150) rotate(-90) translate(0,-3)" font-family="Arial" font-size="12px" font-weight="bold" fill="black" opacity="1">Number of Participants</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-rect role-mark layer_0_marks" role="graphics-object" aria-roledescription="rect mark container"><path aria-label="Stage: 0; Number of Participants: 80; Diagnosis: CN; Count: 80; Percentage: 43.5%" role="graphics-symbol" aria-roledescription="bar" d="M1.923076923076934,180h34.61538461538461v120h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 0; Number of Participants: 66; Diagnosis: EMCI; Count: 66; Percentage: 35.9%" role="graphics-symbol" aria-roledescription="bar" d="M1.923076923076934,81h34.61538461538461v99h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 0; Number of Participants: 38; Diagnosis: LMCI; Count: 38; Percentage: 20.7%" role="graphics-symbol" aria-roledescription="bar" d="M1.923076923076934,23.99999999999999h34.61538461538461v57.000000000000014h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 0; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M1.923076923076934,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 1; Number of Participants: 51; Diagnosis: CN; Count: 51; Percentage: 37.2%" role="graphics-symbol" aria-roledescription="bar" d="M40.384615384615394,223.5h34.61538461538461v76.5h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 1; Number of Participants: 56; Diagnosis: EMCI; Count: 56; Percentage: 40.9%" role="graphics-symbol" aria-roledescription="bar" d="M40.384615384615394,139.5h34.61538461538461v84h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 1; Number of Participants: 30; Diagnosis: LMCI; Count: 30; Percentage: 21.9%" role="graphics-symbol" aria-roledescription="bar" d="M40.384615384615394,94.49999999999999h34.61538461538461v45.000000000000014h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 1; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M40.384615384615394,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 2; Number of Participants: 5; Diagnosis: CN; Count: 5; Percentage: 13.9%" role="graphics-symbol" aria-roledescription="bar" d="M78.84615384615385,286.5h34.61538461538461v7.5h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 2; Number of Participants: 11; Diagnosis: EMCI; Count: 11; Percentage: 30.6%" role="graphics-symbol" aria-roledescription="bar" d="M78.84615384615385,270h34.61538461538461v16.5h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 2; Number of Participants: 16; Diagnosis: LMCI; Count: 16; Percentage: 44.4%" role="graphics-symbol" aria-roledescription="bar" d="M78.84615384615385,246.00000000000003h34.61538461538461v23.99999999999997h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 2; Number of Participants: 4; Diagnosis: AD; Count: 4; Percentage: 11.1%" role="graphics-symbol" aria-roledescription="bar" d="M78.84615384615385,294h34.61538461538461v6h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 3; Number of Participants: 5; Diagnosis: CN; Count: 5; Percentage: 31.3%" role="graphics-symbol" aria-roledescription="bar" d="M117.30769230769232,291h34.61538461538461v7.5h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 3; Number of Participants: 4; Diagnosis: EMCI; Count: 4; Percentage: 25.0%" role="graphics-symbol" aria-roledescription="bar" d="M117.30769230769232,285h34.61538461538461v6h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 3; Number of Participants: 6; Diagnosis: LMCI; Count: 6; Percentage: 37.5%" role="graphics-symbol" aria-roledescription="bar" d="M117.30769230769232,276h34.61538461538461v9h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 3; Number of Participants: 1; Diagnosis: AD; Count: 1; Percentage: 6.3%" role="graphics-symbol" aria-roledescription="bar" d="M117.30769230769232,298.5h34.61538461538461v1.5h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 4; Number of Participants: 3; Diagnosis: CN; Count: 3; Percentage: 23.1%" role="graphics-symbol" aria-roledescription="bar" d="M155.76923076923077,295.5h34.61538461538461v4.5h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 4; Number of Participants: 4; Diagnosis: EMCI; Count: 4; Percentage: 30.8%" role="graphics-symbol" aria-roledescription="bar" d="M155.76923076923077,289.5h34.61538461538461v6h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 4; Number of Participants: 6; Diagnosis: LMCI; Count: 6; Percentage: 46.2%" role="graphics-symbol" aria-roledescription="bar" d="M155.76923076923077,280.5h34.61538461538461v9h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 4; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M155.76923076923077,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 5; Number of Participants: 1; Diagnosis: CN; Count: 1; Percentage: 3.1%" role="graphics-symbol" aria-roledescription="bar" d="M194.23076923076923,274.5h34.61538461538461v1.5h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 5; Number of Participants: 3; Diagnosis: EMCI; Count: 3; Percentage: 9.4%" role="graphics-symbol" aria-roledescription="bar" d="M194.23076923076923,270h34.61538461538461v4.5h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 5; Number of Participants: 12; Diagnosis: LMCI; Count: 12; Percentage: 37.5%" role="graphics-symbol" aria-roledescription="bar" d="M194.23076923076923,252h34.61538461538461v18h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 5; Number of Participants: 16; Diagnosis: AD; Count: 16; Percentage: 50.0%" role="graphics-symbol" aria-roledescription="bar" d="M194.23076923076923,276h34.61538461538461v24h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 6; Number of Participants: 7; Diagnosis: CN; Count: 7; Percentage: 8.3%" role="graphics-symbol" aria-roledescription="bar" d="M232.6923076923077,256.5h34.61538461538461v10.5h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 6; Number of Participants: 19; Diagnosis: EMCI; Count: 19; Percentage: 22.6%" role="graphics-symbol" aria-roledescription="bar" d="M232.6923076923077,228h34.61538461538461v28.5h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 6; Number of Participants: 36; Diagnosis: LMCI; Count: 36; Percentage: 42.9%" role="graphics-symbol" aria-roledescription="bar" d="M232.6923076923077,174.00000000000003h34.61538461538461v53.99999999999997h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 6; Number of Participants: 22; Diagnosis: AD; Count: 22; Percentage: 26.2%" role="graphics-symbol" aria-roledescription="bar" d="M232.6923076923077,267h34.61538461538461v33h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 7; Number of Participants: 1; Diagnosis: CN; Count: 1; Percentage: 2.3%" role="graphics-symbol" aria-roledescription="bar" d="M271.1538461538462,277.5h34.61538461538461v1.5h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 7; Number of Participants: 8; Diagnosis: EMCI; Count: 8; Percentage: 18.2%" role="graphics-symbol" aria-roledescription="bar" d="M271.1538461538462,265.5h34.61538461538461v12h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 7; Number of Participants: 21; Diagnosis: LMCI; Count: 21; Percentage: 47.7%" role="graphics-symbol" aria-roledescription="bar" d="M271.1538461538462,234h34.61538461538461v31.5h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 7; Number of Participants: 14; Diagnosis: AD; Count: 14; Percentage: 31.8%" role="graphics-symbol" aria-roledescription="bar" d="M271.1538461538462,279h34.61538461538461v21h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 8; Number of Participants: 1; Diagnosis: CN; Count: 1; Percentage: 1.3%" role="graphics-symbol" aria-roledescription="bar" d="M309.61538461538464,240h34.61538461538461v1.4999999999999716h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 8; Number of Participants: 5; Diagnosis: EMCI; Count: 5; Percentage: 6.4%" role="graphics-symbol" aria-roledescription="bar" d="M309.61538461538464,232.5h34.61538461538461v7.5h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 8; Number of Participants: 33; Diagnosis: LMCI; Count: 33; Percentage: 42.3%" role="graphics-symbol" aria-roledescription="bar" d="M309.61538461538464,183h34.61538461538461v49.5h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 8; Number of Participants: 39; Diagnosis: AD; Count: 39; Percentage: 50.0%" role="graphics-symbol" aria-roledescription="bar" d="M309.61538461538464,241.49999999999997h34.61538461538461v58.50000000000003h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 9; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M348.0769230769231,283.5h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 9; Number of Participants: 0; Diagnosis: EMCI; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M348.0769230769231,283.5h34.61538461538461v0h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 9; Number of Participants: 5; Diagnosis: LMCI; Count: 5; Percentage: 31.3%" role="graphics-symbol" aria-roledescription="bar" d="M348.0769230769231,276h34.61538461538461v7.5h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 9; Number of Participants: 11; Diagnosis: AD; Count: 11; Percentage: 68.8%" role="graphics-symbol" aria-roledescription="bar" d="M348.0769230769231,283.5h34.61538461538461v16.5h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 10; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M386.53846153846155,300h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 10; Number of Participants: 0; Diagnosis: EMCI; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M386.53846153846155,300h34.61538461538461v0h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 10; Number of Participants: 0; Diagnosis: LMCI; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M386.53846153846155,300h34.61538461538461v0h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 10; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M386.53846153846155,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 11; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M425,265.5h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 11; Number of Participants: 1; Diagnosis: EMCI; Count: 1; Percentage: 2.4%" role="graphics-symbol" aria-roledescription="bar" d="M425,264h34.61538461538461v1.5h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 11; Number of Participants: 17; Diagnosis: LMCI; Count: 17; Percentage: 41.5%" role="graphics-symbol" aria-roledescription="bar" d="M425,238.5h34.61538461538461v25.5h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 11; Number of Participants: 23; Diagnosis: AD; Count: 23; Percentage: 56.1%" role="graphics-symbol" aria-roledescription="bar" d="M425,265.5h34.61538461538461v34.5h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 12; Number of Participants: 1; Diagnosis: CN; Count: 1; Percentage: 2.2%" role="graphics-symbol" aria-roledescription="bar" d="M463.46153846153845,264h34.61538461538461v1.5h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 12; Number of Participants: 5; Diagnosis: EMCI; Count: 5; Percentage: 11.1%" role="graphics-symbol" aria-roledescription="bar" d="M463.46153846153845,256.5h34.61538461538461v7.5h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 12; Number of Participants: 16; Diagnosis: LMCI; Count: 16; Percentage: 35.6%" role="graphics-symbol" aria-roledescription="bar" d="M463.46153846153845,232.5h34.61538461538461v24h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 12; Number of Participants: 23; Diagnosis: AD; Count: 23; Percentage: 51.1%" role="graphics-symbol" aria-roledescription="bar" d="M463.46153846153845,265.5h34.61538461538461v34.5h-34.61538461538461Z" fill="#EE6677"/></g><g class="mark-text role-mark layer_1_marks" role="graphics-object" aria-roledescription="text mark container"><text aria-label="Stage: 0; Total: 184; Total Sample Size: 184" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(19.23076923076924,13)" font-family="sans-serif" font-size="9px" fill="black">184</text><text aria-label="Stage: 0; Total: 184; Total Sample Size: 184" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(19.23076923076924,13)" font-family="sans-serif" font-size="9px" fill="black">184</text><text aria-label="Stage: 0; Total: 184; Total Sample Size: 184" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(19.23076923076924,13)" font-family="sans-serif" font-size="9px" fill="black">184</text><text aria-label="Stage: 0; Total: 184; Total Sample Size: 184" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(19.23076923076924,13)" font-family="sans-serif" font-size="9px" fill="black">184</text><text aria-label="Stage: 1; Total: 137; Total Sample Size: 137" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(57.6923076923077,13)" font-family="sans-serif" font-size="9px" fill="black">137</text><text aria-label="Stage: 1; Total: 137; Total Sample Size: 137" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(57.6923076923077,13)" font-family="sans-serif" font-size="9px" fill="black">137</text><text aria-label="Stage: 1; Total: 137; Total Sample Size: 137" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(57.6923076923077,13)" font-family="sans-serif" font-size="9px" fill="black">137</text><text aria-label="Stage: 1; Total: 137; Total Sample Size: 137" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(57.6923076923077,13)" font-family="sans-serif" font-size="9px" fill="black">137</text><text aria-label="Stage: 2; Total: 36; Total Sample Size: 36" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(96.15384615384616,13)" font-family="sans-serif" font-size="9px" fill="black">36</text><text aria-label="Stage: 2; Total: 36; Total Sample Size: 36" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(96.15384615384616,13)" font-family="sans-serif" font-size="9px" fill="black">36</text><text aria-label="Stage: 2; Total: 36; Total Sample Size: 36" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(96.15384615384616,13)" font-family="sans-serif" font-size="9px" fill="black">36</text><text aria-label="Stage: 2; Total: 36; Total Sample Size: 36" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(96.15384615384616,13)" font-family="sans-serif" font-size="9px" fill="black">36</text><text aria-label="Stage: 3; Total: 16; Total Sample Size: 16" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(134.61538461538464,13)" font-family="sans-serif" font-size="9px" fill="black">16</text><text aria-label="Stage: 3; Total: 16; Total Sample Size: 16" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(134.61538461538464,13)" font-family="sans-serif" font-size="9px" fill="black">16</text><text aria-label="Stage: 3; Total: 16; Total Sample Size: 16" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(134.61538461538464,13)" font-family="sans-serif" font-size="9px" fill="black">16</text><text aria-label="Stage: 3; Total: 16; Total Sample Size: 16" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(134.61538461538464,13)" font-family="sans-serif" font-size="9px" fill="black">16</text><text aria-label="Stage: 4; Total: 13; Total Sample Size: 13" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(173.0769230769231,13)" font-family="sans-serif" font-size="9px" fill="black">13</text><text aria-label="Stage: 4; Total: 13; Total Sample Size: 13" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(173.0769230769231,13)" font-family="sans-serif" font-size="9px" fill="black">13</text><text aria-label="Stage: 4; Total: 13; Total Sample Size: 13" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(173.0769230769231,13)" font-family="sans-serif" font-size="9px" fill="black">13</text><text aria-label="Stage: 4; Total: 13; Total Sample Size: 13" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(173.0769230769231,13)" font-family="sans-serif" font-size="9px" fill="black">13</text><text aria-label="Stage: 5; Total: 32; Total Sample Size: 32" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(211.53846153846155,13)" font-family="sans-serif" font-size="9px" fill="black">32</text><text aria-label="Stage: 5; Total: 32; Total Sample Size: 32" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(211.53846153846155,13)" font-family="sans-serif" font-size="9px" fill="black">32</text><text aria-label="Stage: 5; Total: 32; Total Sample Size: 32" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(211.53846153846155,13)" font-family="sans-serif" font-size="9px" fill="black">32</text><text aria-label="Stage: 5; Total: 32; Total Sample Size: 32" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(211.53846153846155,13)" font-family="sans-serif" font-size="9px" fill="black">32</text><text aria-label="Stage: 6; Total: 84; Total Sample Size: 84" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(250,13)" font-family="sans-serif" font-size="9px" fill="black">84</text><text aria-label="Stage: 6; Total: 84; Total Sample Size: 84" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(250,13)" font-family="sans-serif" font-size="9px" fill="black">84</text><text aria-label="Stage: 6; Total: 84; Total Sample Size: 84" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(250,13)" font-family="sans-serif" font-size="9px" fill="black">84</text><text aria-label="Stage: 6; Total: 84; Total Sample Size: 84" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(250,13)" font-family="sans-serif" font-size="9px" fill="black">84</text><text aria-label="Stage: 7; Total: 44; Total Sample Size: 44" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(288.4615384615385,13)" font-family="sans-serif" font-size="9px" fill="black">44</text><text aria-label="Stage: 7; Total: 44; Total Sample Size: 44" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(288.4615384615385,13)" font-family="sans-serif" font-size="9px" fill="black">44</text><text aria-label="Stage: 7; Total: 44; Total Sample Size: 44" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(288.4615384615385,13)" font-family="sans-serif" font-size="9px" fill="black">44</text><text aria-label="Stage: 7; Total: 44; Total Sample Size: 44" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(288.4615384615385,13)" font-family="sans-serif" font-size="9px" fill="black">44</text><text aria-label="Stage: 8; Total: 78; Total Sample Size: 78" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(326.92307692307696,13)" font-family="sans-serif" font-size="9px" fill="black">78</text><text aria-label="Stage: 8; Total: 78; Total Sample Size: 78" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(326.92307692307696,13)" font-family="sans-serif" font-size="9px" fill="black">78</text><text aria-label="Stage: 8; Total: 78; Total Sample Size: 78" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(326.92307692307696,13)" font-family="sans-serif" font-size="9px" fill="black">78</text><text aria-label="Stage: 8; Total: 78; Total Sample Size: 78" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(326.92307692307696,13)" font-family="sans-serif" font-size="9px" fill="black">78</text><text aria-label="Stage: 9; Total: 16; Total Sample Size: 16" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(365.3846153846154,13)" font-family="sans-serif" font-size="9px" fill="black">16</text><text aria-label="Stage: 9; Total: 16; Total Sample Size: 16" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(365.3846153846154,13)" font-family="sans-serif" font-size="9px" fill="black">16</text><text aria-label="Stage: 9; Total: 16; Total Sample Size: 16" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(365.3846153846154,13)" font-family="sans-serif" font-size="9px" fill="black">16</text><text aria-label="Stage: 9; Total: 16; Total Sample Size: 16" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(365.3846153846154,13)" font-family="sans-serif" font-size="9px" fill="black">16</text><text aria-label="Stage: 10; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(403.84615384615387,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 10; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(403.84615384615387,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 10; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(403.84615384615387,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 10; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(403.84615384615387,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 11; Total: 41; Total Sample Size: 41" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(442.3076923076923,13)" font-family="sans-serif" font-size="9px" fill="black">41</text><text aria-label="Stage: 11; Total: 41; Total Sample Size: 41" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(442.3076923076923,13)" font-family="sans-serif" font-size="9px" fill="black">41</text><text aria-label="Stage: 11; Total: 41; Total Sample Size: 41" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(442.3076923076923,13)" font-family="sans-serif" font-size="9px" fill="black">41</text><text aria-label="Stage: 11; Total: 41; Total Sample Size: 41" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(442.3076923076923,13)" font-family="sans-serif" font-size="9px" fill="black">41</text><text aria-label="Stage: 12; Total: 45; Total Sample Size: 45" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(480.7692307692308,13)" font-family="sans-serif" font-size="9px" fill="black">45</text><text aria-label="Stage: 12; Total: 45; Total Sample Size: 45" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(480.7692307692308,13)" font-family="sans-serif" font-size="9px" fill="black">45</text><text aria-label="Stage: 12; Total: 45; Total Sample Size: 45" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(480.7692307692308,13)" font-family="sans-serif" font-size="9px" fill="black">45</text><text aria-label="Stage: 12; Total: 45; Total Sample Size: 45" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(480.7692307692308,13)" font-family="sans-serif" font-size="9px" fill="black">45</text></g><g class="mark-group role-legend" role="graphics-symbol" aria-roledescription="legend" aria-label="Symbol legend for fill color with 4 values: CN, EMCI, LMCI, AD"><g transform="translate(0,-29)"><path class="background" aria-hidden="true" d="M0,0h181v11h-181Z" pointer-events="none"/><g><g class="mark-group role-legend-entry"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-group role-scope" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h31.8876953125v11h-31.8876953125Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#4477AA" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="11px" fill="#000" opacity="1">CN</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(42,0)"><path class="background" aria-hidden="true" d="M0,0h43.5v11h-43.5Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#66CCEE" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="11px" fill="#000" opacity="1">EMCI</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(96,0)"><path class="background" aria-hidden="true" d="M0,0h42.28076171875v11h-42.28076171875Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#228833" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="11px" fill="#000" opacity="1">LMCI</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(149,0)"><path class="background" aria-hidden="true" d="M0,0h31.28076171875v11h-31.28076171875Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#EE6677" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="11px" fill="#000" opacity="1">AD</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-title"><g transform="translate(250,-47)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-text role-title-text" role="graphics-symbol" aria-roledescription="title" aria-label="Title text 'Distribution of Disease Stages by Diagnosis, DEBM'" pointer-events="none"><text text-anchor="middle" transform="translate(0,1)" font-family="sans-serif" font-size="14px" font-weight="normal" fill="#000" opacity="1">Distribution of Disease Stages by Diagnosis, DEBM</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g></g></g></svg>